DALLAS, Aug. 3, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Hard to Treat Diseases Inc. (Pink Sheets:HTDS). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Hard to Treat Diseases Inc. (Pink Sheets:HTDS) should be of particular interest to other comparable companies: Immunomedics Inc. (Nasdaq:IMMU), Human Genome Sciences (Nasdaq:HGSI), Johnson & Johnson (NYSE:JNJ) and ZymoGenetics Inc. (Nasdaq:ZGEN).
It is available at: http://www.stockpreacher.com/n/HTDS
Hard to Treat Diseases Inc. (HTDS) is an emerging company focused on the development and licensing of proprietary technologies. HTDS acquired China-based Shenzhen Mellow Hope Pharm Industrial Co. Ltd, the biggest exporter of biological vaccines in China. It also has a controlling interest in Slavica BioChem, a Serbian company whose primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, hepatitis C and HIV.
In the report, the analyst notes:
"HTDS' strategy to increase shareholder value, separate from the operating performance of operating subsidiaries, is by spinning off and distributing shares of its wholly owned subsidiaries in the form of a special dividend to the Company's shareholders.
"HTDS secured a niche in the fast-emerging global vaccine market following the acquisition of Mellow Hope in February. Mellow Hope's current revenues are reportedly in excess of $15 million and growing. As the biggest exporter of biological vaccines in the China, Mellow Hope has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; blood-based products including human rabies immunoglobulin; and active pharmaceutical ingredients (or APIs) for injection such as celestatin."
To read the entire report visit: http://www.stockpreacher.com/n/HTDS
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.
CONTACT: StockPreacher.com
Jeff Bishop
(469)-252-3505
press@beaconequity.com
